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Abstract
Background: Subacromial pain syndrome (SAPS) accounts for around 50 % of all cases of shoulder pain. The most
commonly used treatments are glucocorticosteroid (steroid) injections and exercise therapy; however, despite
treatment SAPS patients often experience relapse of their symptoms. Therefore the clinical effect of combining
steroid and exercise therapy is highly relevant to clarify. The aim of this randomized controlled trial was to
investigate if exercise therapy added to steroid injection in patients with SAPS will improve the effect of the
injection therapy on shoulder pain.
Methods: In this two-arm randomized trial running over 26 weeks, patients with unilateral shoulder pain (> 4
weeks) and thickened subacromial bursa (> 2 mm on US) were included. At baseline all participants received two
steroid injections into the painful shoulder with an interval of one week. Subsequently they were randomized
(1:1) to either 10 weeks exercise of the involved shoulder (intervention group) or exercise of the uninvolved
shoulder (control group). The patients were re-examined after the exercise program (at week 13) and again at
week 26. The primary outcome assessed after 26 weeks was change in shoulder pain analyzed using the
intention-to-treat principle (non-responder imputation).
Results: Ninety-nine SAPS patients (58 female) participated (49 intervention/50 control). At both follow up visits
(week 13 and 26) no statistically significant between-group differences in pain changes on a visual analog scale
(mm) were seen (13 weeks: pain at rest 1.7 (95 % CI –3.6 to 7.0; P = 0.53); pain in activity 2.2 (95 % CI –6.5 to
10.9; P = 0.61), 26 weeks: rest 5.6 (95 % CI –0.9 to 12.1; P = 0.09); activity 2.2 (95 % CI –6.8 to 11.2; P = 0.62). The
reduction in pain was most evident in the control group at all four pain measurements. The only difference
between groups was seen by US examination at week 13, where fewer participants with impingement were
observed in the intervention group compared with the controls (9 vs. 19 participants; P = 0.03).
Conclusion: Exercise therapy in the painful shoulder in SAPS patients did not improve the effectiveness of
steroid injections for shoulder pain in patients with unilateral SAPS and enlarged subacromial bursa on US
examination.
Trial registration: ClinicalTrials.gov (NCT01506804). Registration date 5 May 2011.
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Background
Shoulder pain is common and accounts for around 12 %
of the contacts in primary care [1, 2] with subacromial
pain syndrome (SAPS) accounting for approximately 50
% of cases of shoulder pain [3, 4]. SAPS is suggested to
be a more comprehensive diagnosis than subacromial
impingement to describe unspecific shoulder pain. The
SAPS definition can be used as an umbrella diagnosis
for all conditions affecting the structures of the subacro-
mial space including enlarged subacromial bursa, rotator
cuff and biceps tendon ruptures, and other pathological
changes in the tendons [3, 5, 6].
The most commonly used treatments for SAPS are
glucocorticosteroid (steroid) injection and exercise ther-
apy. SAPS is often recurrent, so patients often receive an
unstructured mix of both treatments [3, 7–10]. Effective-
ness of each treatment has been demonstrated in the
short term on pain and function. The choice of treat-
ment is ambiguous and there is no standardized treat-
ment algorithm, and the long-term effects of a stringent
protocol investigating steroid injection and exercise ther-
apy in combination have not been investigated [3, 7–10].
Inflammation and pain may impair muscle function
[11]. Experimental studies have shown that pain alters
muscle recruitment strategies and strength [12–14]. Ac-
cordingly, it is plausible that pharmacological suppres-
sion of inflammation and pain prior to exercise may
enhance the effect of the exercise. Also, exercise may
suppress the inflammation [15] and may per se have
additional effects on the pharmacological treatment of
the inflammation [16]. The aim of the current study was
to test whether the effect of steroid injections on SAPS
may be improved by adding exercise therapy.
Methods
We conducted an assessor-blinded, two-arm, parallel-
group, randomized controlled trial running over 26
weeks; primary outcome was assessed after 26 weeks
(primary end point). A methodological protocol was de-
veloped and registered with ClinicalTrials.gov before the
trial began (NCT01506804) 05/05-2011. The protocol
was also approved by the Regional Health Research Eth-
ics Committee (H-4-2010-022). The trial was conducted
in accordance with the Helsinki Declaration and this
paper follows the CONSORT reporting guidelines [17].
All participants signed an informed consent form before
participating in the study.
Setting and eligibility criteria
Participants were recruited from a rheumatology out-
patient clinic at a Hospital in Denmark and by advertis-
ing on a specific site on the Internet for participants for
clinical trials, between May 2009 and April 2011.
Inclusion criteria were age 18 to 70 years and unilat-
eral shoulder pain provoked by active shoulder abduc-
tion and lasting at least 4 weeks. In addition, an
enlarged subacromial bursa (≥ 2 mm) as assessed by
ultrasound imaging (US) in the symptomatic shoulder
was required.
Exclusion criteria included complete or partial rup-
tures of the biceps or rotator cuff tendons assessed by
US [18], symptoms originating from the cervical spine,
other conditions explaining the shoulder pain, capsular
pattern restriction, contraindications to steroid or lido-
caine or exercise therapy, steroid injection of either
shoulder within the previous 3 months, and any previous
shoulder surgery.
Procedures
Potentially eligible participants having received oral and
written information about the study were invited to a
clinical examination by a rheumatologist and an US
examination of the shoulder. Upon inclusion, and subse-
quent to baseline assessments, the participants received
two US-guided injections of steroid in the thickened
bursa in the painful shoulder, given with an interval of 1
week. Two injections were given to increase the chances
of a clinical effect. After the second injection, the partici-
pants were randomized. The intervention group received
a training program for the painful shoulder. The control
group received the same program for the asymptomatic
shoulder. Both groups commenced the training program
1 week after receiving the second injection. The exercise
program lasted for 10 weeks.
Randomization, treatment allocation and blinding
The participants were randomized 1:1 in blocks of 4–6
using an envelope-based lottery. The individual alloca-
tions were held in sealed opaque envelopes. The leader
of the project (KE), who was blinded to all clinical data,
made the allocation. Due to the type of treatment in
both the intervention and control group neither the par-
ticipant nor the person performing the intervention were
blinded. The persons performing the clinical tests and
training sessions in both intervention and control group
were blinded to the self-reported shoulder function. The
person performing all the statistical analysis was blinded
to group allocation.
Interventions
Injections
The two injections given (separated by 1 week) each
contained 1 mL methylprednisolone (40 mg Depo-
Medrol®, Pfizer) and 2 mL lidocaine (5 %). All injections
were given US-guided, as it has been shown that the ef-
fect on pain and function is superior to blind injections
[19–21]. An experienced radiologist specializing in US
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(STP) gave the injections. The US examinations were car-
ried out using a Logic E9 with a 15 MHz linear array
transducer (General Electric Medical System, Milwaukee,
WI, USA).
Patients sat in an upright position. The arm was posi-
tioned behind the lower back, with the elbow flexed.
The US probe was placed on the lateral contour of the
shoulder parallel to the underlying supraspinatus ten-
don. The injection was performed with a lateral ap-
proach and real-time US evidence of the bolus being
correctly distributed in the enlarged bursa.
Exercise
The exercise intervention followed the descriptors by
Toigo & Boutellier [22]. The exercise program consisted
of three sessions per week for 10 weeks, with one session
per week being supervised by a physiotherapist; the
other was home based. Additional file 1 describes the
exercise program in detail. If the exercises caused shoul-
der pain rated as > 50 mm on a 10–mm visual analog
scale (VAS), which did not subside immediately, loading
was reduced. A sensation of post exercise muscle fatigue
and delayed onset muscle soreness was regarded as ac-
ceptable. The same exercise program was used in both
groups, but on different shoulders (involved/non-in-
volved as per the allocation).
During the first 2 weeks of exercise, (phase 1), the
emphasis was on scapula muscle control and strength.
The following 8 weeks (phase 2) aimed at progressive
strengthening of the muscles of the rotator cuff. The
program rationale was to target muscle function deficits
of the scapula prior to targeting muscle function defi-
cits of the rotator cuff muscles [4, 23]. An exercise
diary was used in both groups.
Outcome measurements and assessment
Outcomes were measured at baseline (before the first
injection), at the week-13 visit (after the exercise pro-
gram), and at a 26-week follow-up visit (12 weeks after
cessation of the exercise program). As the purpose of
this study was to assess the effect of stringent combined
pharmacological and exercise therapy the co-primary
outcomes were changes from baseline in current shoul-
der pain during active shoulder abduction and at rest at
the 26-week follow up (primary end point). These pain
measures were assessed on 0–100 mm VAS with an-
chors being 0 = no pain and 100 = worst imaginable
pain. The secondary outcomes were the same pain rat-
ings at week 13; clinical impingement signs (Hawkins-
Kennedy test), US impingement test, subacromial bursa
size on US (size; mm), self-reported shoulder function
(Shoulder Disability Questionnaire (SDQ)), and isomet-
ric muscle strength.
Impingement
In the Hawkins-Kennedy sign the shoulder pain is repro-
duced by shoulder flexion followed by a forced internal
rotation [24]. The test is positive if the shoulder pain is
reproduced. On US-based impingement the acromion
and the humeral head were simultaneously visualized by
US during passive abduction of the shoulder joint. Im-
pingement was indicated if the bursa and/or tendons
were impinged at the edge of the acromial bone. Suba-
cromial bursa enlargement was assessed from US exami-
nations in two positions: (1) with the patients sitting in
an upright position with the arm positioned behind the
back and (2) in the same position but with the hand on
the waist. In both positions, the transducer was moved
until it was over the area where the thickness of the
bursa was most pronounced. The maximal bursa size
was obtained in both positions. We defined a bursa
thickness > 2 mm as enlarged [25].
Isometric muscle strength
IMS was assessed unilaterally (painful shoulder) using a
handheld dynamometer (Commander Power track II,
JTEC Medical, USA). This method has been shown to
be reliable for assessment of muscle strength in the
shoulder and hip [26, 27]. IMS was measured in internal
rotation, external rotation, and abduction, with each
contraction lasting approximately 6 seconds. The abduc-
tion strength was tested in 45° shoulder abduction. IMS
in internal and external rotation was assessed with the
shoulder in the neutral position and the elbow flexed at
90°. All measurements were repeated four times with
10-second intervals and the maximum value was used
for analysis. Standardized instructions and verbal en-
couragement were given [28].
Self-reported shoulder function
Self-reported functional status of the shoulder was
assessed by the SDQ. The questionnaire consists of 16
items assessing pain during the previous 24 h in the
shoulder during activities of daily living [29, 30]. Three
answers are possible in each item: “yes”, “no” and “not
applicable”. The shoulder function is measured as a
score between 0 and 100 % expressing the proportion
of “yes” scores in relation to the total number of an-
swers. The “not applicable” items are not included in
the analysis [31]. A Danish version of the SDQ was not
available, but the English version is validated [3]. Two
people with good English skills translated the test inde-
pendently. The two translated versions were compared
by the translators and the study manager. Any discrep-
ancies in translations were discussed until consensus
was reached.
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Sample size and power considerations
This study was powered as a superiority trial for a com-
parison between the participants allocated to exercise of
the painful shoulder (intervention) and those allocated
to exercise of the non-painful shoulder (control). As-
suming that the intervention produced a reduction in
one of the co-primary outcomes (pain during active
shoulder abduction and pain at rest) that was 10 mm
larger than the control with a standard deviation of 20
mm and a conjectured correlation of 0.7 between the co-
variate (baseline pain) and the response (change in pain),
we calculated that we would need 42 participants per
group to test a two-tailed hypothesis with 80 % power
and a 2.5 % significance level (P < 0.025), using the usual
F test of the group effect in the general linear univariate
model with fixed class effects (group; two levels (inter-
vention vs. control)) with an additional fixed covariate
(baseline pain). To account for attrition we decided to
include 100 patients in total, yielding a power of 88.8 %.
Although we also investigated effects on other outcomes,
we did not power the trial for this because we had no a
priori assumptions about effect sizes in our secondary
outcomes and thus a larger trial may be needed to reli-
ably detect these.
Statistical analysis
All data analyses were carried out according to a pre-
established analysis plan. Analyses were done applying
SAS (v. 9.2; SAS Institute Inc., Cary, NC, USA). All de-
scriptive statistics and tests are reported in accordance
with the recommendations of the Enhancing the Quality
and Transparency Of health Research (EQUATOR) net-
work, as per the Consolidated Standards of Reporting
Trials (CONSORT) statement [32]. In order to evaluate
the empirical distributions of continuous outcomes, vis-
ual inspection was used to suggest whether the assump-
tion of normality was reasonable.
All patients randomized were assessed for efficacy and
safety (i.e., intention-to-treat (ITT) population). At 13
weeks (the end of intervention) and after 26 weeks, the
exercise and control groups were compared using ana-
lysis of covariance (ANCOVA) to analyze mean changes
from baseline in the outcomes. The model included the
change as the dependent variable, with treatment group
as a main effect and the baseline score as an additional
covariate.
The proportion of patients, who were impingement-
positive on US and/or on clinical assessment at the 13-
week and 26-week follow up, were analyzed using the
chi-square test to evaluate the differences between pro-
portions between the exercise and control group and the
group differences are presented as risk differences with
95 % confidence interval.
The baseline observation carried forward (BOCF) ap-
proach was used for patients who did not complete the
study, as this method seems conservative in self-help
management programs; i.e., using a non-responder im-
putation. As this trial was designed as a pragmatic trial,
baseline data were only imputed when the patient did
not attend follow-up visits, and was not based on adher-
ence rate or compliance considerations. Unless stated
otherwise, results are expressed as the mean difference
between the groups and 95 % confidence intervals (95 %
CI) with the associated P values, based on the ANCOVA
model.
Results
The flow of patients through the trial can be seen in
Fig. 1: 99 patients were included in the study. Participant
number 100 volunteered but did not attend the baseline
assessment and was not randomized. Because the treat-
ment allocation was done in blocks we decided to com-
mence the last block of participants even though the last
participant was missing. Characteristics of the study
sample are presented in Table 1. In the intervention
group, 17 participants were lost to follow up; in the con-
trol group 18 patients were lost to follow-up (Fig. 1).
Compliance with exercise
Exercise diaries were only collected from the partici-
pants who completed the study (n = 65) and the compli-
ance rate was calculated for these participants. In the
intervention group 27 of the 33 completers filled in an
exercise diary with an average number of exercise ses-
sions of 29 out of 30 (97 %). In the control group, 31 of
32 participants filled in a diary and the number of exer-
cise sessions was 26 out of 30 (87 %).
Primary outcomes
We found no statistically significant differences between
groups in the co-primary pain outcomes at week 26
(Fig. 2). The group difference in change from baseline in
pain during active abduction was 2.2 mm (95 % CI –6.8
to 11.2; P = 0.62). The group difference in change from
baseline in pain at rest was 5.6 mm (95 % CI –0.9 to
12.1; P = 0.088), potentially in favor of the control group.
At the 13-week follow up the group difference in
change from baseline in pain at rest was 1.7 mm (95 %
CI –3.6 to 6.0; P = 0.53) and the group difference in
change from baseline in pain during shoulder abduction
was 2.2 mm (95 % CI –6.5 to 10.9; P = 0.61), potentially
in favor of the control group.
Secondary outcomes
There were no statistically significant differences be-
tween the groups in thickness of the subacromial bursa
as seen on US, self-reported shoulder function (SDQ),
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clinical impingement test or isometric muscle strength
at the 13-week or 26-week follow up (Table 2). At the
13-week follow up, there was a statistically significant
difference between groups in the proportion of partici-
pants with a positive US impingement test, as only 18
% had a positive test in the intervention group as com-
pared 38 % with a positive test in the control group
(risk difference 0.20 (95 % CI 0.02 to 0.37); P = 0.03)
(Table 2).
Discussion
We investigated the effects of unilateral exercise therapy
after steroid injections in the subacromial bursa in pa-
tients with SAPS. The exercise intervention was com-
pared to exercise of the asymptomatic shoulder. There
was no difference between the groups in the primary
outcomes of shoulder pain at rest and activity at the 26-
week follow up, although a tendency towards less pain at
rest in the control group was observed. A group differ-
ence in US impingement at week 13 in favor of the
intervention group was observed; however, more partici-
pants in the control group (25 vs. 16) had US impinge-
ment at baseline. This indicates that the result should be
interpreted with caution. The difference was not main-
tained at week 26. No group differences were observed
in any of the other secondary outcomes.
The equal beneficial change in pain in rest and activity
in both groups is in agreement with a previous study of
patients with SAPS [33]. In that study the exercise inter-
vention was more intense, with exercise twice daily.
These extensive exercises improved the shoulder func-
tion. This may indicate that any exercise program can
improve shoulder pain, but intensive exercise programs
are necessary in order to improve shoulder function.
Fig. 1 Study flow chart
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This is supported by a study by Bennell et al. [34] in
which there was no difference between an exercise and a
placebo group after 10 weeks of daily therapy. However,
there was a statistically significant difference between
groups 12 weeks after the end of the interventions. As
no standardized intervention was offered in the follow-
up period the results must be interpreted tentatively.
In contrast to other studies investigating the effect of
exercise therapy we added no other physiotherapy tech-
niques, such as manual therapy, to the training or con-
trol interventions, thus minimising the bias of a mixed
intervention [33, 34].
In our study, we observed a minor increase in muscle
strength in both groups, but no differences between
Fig. 2 Group patterns of changes from baseline in self-reported pain at rest (a) and during activity (b). VAS visual analog scale, GC glucocorticosteroid
Table 1 Baseline characteristics for all randomized patients
Intervention (n = 49)
Mean (SD)
Control (n = 50)
Mean (SD)
Combined (n = 99)
Mean (SD)
Min Max
Age (years) 49.4 (13.1) 47.7 (13.3) 48.5 (13.1) 18.1 69.1
Female, n 30 (61 %)b 28 (56 %)b 58 (59 %)b - -
Pain rest, mm VAS 5 (0 to 24)a 11 (0 to 30)a 7 (0 to 29)a 0 77
Pain activity, mm VAS 38 (19 to 60)a 48 (25 to 62)a 45 (23 to 62)a 0 100
Ultrasound variables
Clinical impingement, yes 45 (92 %)b 45 (90 %)b 90 (91 %)b - -
Ultrasound impingement, yes 16 (34 %)b 25 (50 %)b 41 (42 %)b - -
Bursa thickness, mm 2.63 (0.59) 2.74 (0.82) 2.68 (0.71) 1.6 5.4
Shoulder Disability Questionnaire
Percentage score in difficulty performing
shoulder task, 0–100 %
65.9 (24.8) 68.4 (20.8) 67.1 (22.8) 9.1 100
Muscle strength
MVC abduction, N 70.4 (48.4 to 103.0)a 63.8 (44.0 to 85.8)a 67.1 (46.2 to 94.6)a 24.2 209.0
MVC internal rotation, N 138.0 (110.0 to 184.0)a 118.0 (81.4to 167.0)a 126.0 (99.0 to 171.0)a 41.8 325.0
MVC external rotation, N 112.0 (85.8 to 136.0)a 99.0 (81.4to 129.0)a 104.0 (81.4 to 134.0)a 39.6 193.0
Data are presented as mean (SD) except where stated otherwise. VAS visual analog scale, MVC maximal voluntary contraction. aData are median (interquartile
range). bData are number of participants (%)
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groups. The intensity of our exercise program is com-
parable to the standard care offered to patients with
SAPS in clinical practice [8, 9, 35–37]. Furthermore, our
exercise intervention is in accordance with the newest
clinical guideline for SAPS, in which US-guided steroid
injections are also recommended as a part of the man-
agement of SAPS [3]. There is no consensus on the
number of steroid injections needed in patients with
SAPS, thus our choice of two injections was pragmatic
and based on our clinical experience. One might argue
that despite a rather intensive treatment, the changes in
all assessed parameters from baseline were minor in
both groups. This may underline the fact that there is no
highly effective treatment for patients with SAPS and
enlarged bursa.
Another study comparing exercise therapy after ster-
oid injection with exercise therapy alone [35] found no
difference between the groups in pain and function.
Even though that study investigated steroid injection as
an add-on to exercise, as opposed to our study, the re-
sults of both studies indicate that a combination of the
two treatment strategies does not improve the treatment
outcome in SAPS. This suggests that the choice of injec-
tion, exercise, or their combination, must depend on an
individual assessment including patient and physician
preferences.
Patients with SAPS form a heterogeneous group and
clinical tests used to verify specific diagnoses and guide
treatment are not particularly reliable or valid [6, 38].
It has been highlighted that the uncertain clinical
classification may affect the outcomes of clinical
studies [35]. In an attempt to overcome this problem,
the participants in our study were included based on
subacromial bursa enlargement identified on US. To
our knowledge this is the first study using a stan-
dardized US examination to define the study popula-
tion in SAPS. There is no consensus on the
threshold to define pathological thickening of the
subacromial bursa, but the majority of the literature
applies a bursa thickness of < 2 mm as normal
[25, 39, 40]. Albeit arbitrary, we used this threshold
as an inclusion criterion and our study population
can be considered as having SAPS with concomitant
US-based pathological change. We also used US to
rule out any tendon tear of the rotator cuff and bi-
ceps tendon. The use of US as the first choice im-
aging modality in patients with SAPS is in agreement
with the newest guidelines [3].
Our cohort reflected the general population of persons
with shoulder complaints as the mean age was around
50 years and the majority was women [1, 2]. As ex-
plained to the control group, the intervention on the
contralateral shoulder in our study may indeed be sus-
pected of inducing a cross-over effect. With respect to
muscle strength, gains in the untrained extremity have
been reported to account for about one third of the
Table 2 Changes from baseline in secondary outcomes after the exercise program (13 weeks) and after 26 weeks Analyses were
based on the Intention to Treat Population.”
13 weeks 26 weeks
Painful shoulder Interv.
(n = 49)
Cont.
(n = 50)
Group difference P Interv.
(n = 49)
Cont.
(n = 50)
Group difference P
Mean (SE) Mean (SE) Mean (95 % CI) Mean (SE) Mean (SE) Mean (95 % CI)
Ultrasound variables
Bursa size decrease (mm) –0.16 (0.08) –0.30 (0.08) 0.14 (–0.10 to 0.37 0.25 –0.16 (0.08) –0.04 (0.08) –0.13 (–0.36 to 0.10) 0.27
Number of positive US
Impingement
(positive baseline)
9 (18 %)a
(16 (34 %))
19 (38 %)a
(25(50 %))
–0.20 (–0.02 to –0.37)b 0.030c 14 (29 %)a
(16 (34 %))
23 (46 %)a
(25(50 %))
–0.17 (–0.36 to 0.01)b 0.073c
Positive clinical
impingement
(positive baseline)
38 (78 %)a
(45 (92 %))
42 (84.%)a
(45 (90 %))
–0.06 (–0.22 to 0.09)b 0.42c 40 (82 %)a
(45 (92 %))
47 (94 %)a
(45 (90 %))
–0.12 (–0.25 to 0.00)b 0.059c
Shoulder Disability Questionnaire
Decrease (percentage)
in difficulty performing
shoulder task (0–100 %)
–26 (4) –22 (4) –4 (–16 to 7) 0.44 –18 (4 %) –16 (4) –2 (–13 to 10) 0.73
Muscle strength
MVC abduction (n) 4.6 (2.5) 3.7 (2.5) 0.9 (–6.2 to 7.9) 0.80 0.5 (2.4) 1.4 (2.4) –0.9 (–7.5 to 5.7) 0.80
MVC internal rotation (n) 0.8 (3.2) 3.6 (3.1) –2.8 (–11.6 to 5.9) 0.52 0.1 (3.1) –1.5 (3.1) 1.6 (–7.2 to 10.3) 0.71
MVC external rotation (n) 7.0 (2.4) 5.8 (2.4) 1.2 (–5.6 to 8.0) 0.72 –1.5 (2.2) 2.5 (2.2) –4.1 (–10.2 to 2.1) 0.20
Analyses were based on the intention-to-treat population. Intervent. intervention group, Cont. control group, SE standard error, CI confidence interval, US ultrasound,
MVC maximal voluntary contraction. aData are number of participants (%). bData are risk differences (95 % CI). cBased on the Chi2 test of proportions
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improved strength in the trained extremity [30]. This
cross-over might be a limitation of our study and in sup-
port of a cross-over effect, our results indicated that the
control group increased their external shoulder rotation
muscle strength in the untrained, painful arm. However,
the absence of increased muscle strength in abduction
and internal rotation in both groups to some extent con-
tradicts this bias. Similarly, an effect of the control exer-
cise on pain is certainly possible. A study has shown
improvements in knee pain following isolated hip ab-
ductor strengthening exercises [41]. This consideration
also suggests that contralateral or general exercises can
be used in cases where exercises of the involved shoul-
der cannot be accomplished. The reason for choosing
training of the contralateral shoulder as control, despite
the described effects of this training, was owed to the
well-known positive effect of attention from a health
professional. In order to avoid this bias, we decided that
the persons in both groups should have exactly the same
attention from a physiotherapist. Further, the additional
value of exercise therapy might be less pronounced in
the dominant arm, but this was not recorded and there-
fore cannot be explored.
It is a limitation of our study that the exercise com-
pliance was only evaluated in the completer partici-
pants, and it is not unlikely that the participants lost
to follow up had poor adherence to the programs.
Nevertheless, the compliance was comparable between
groups, which indicates that bias due to difference in
exercise compliance was small in our study. Another
limitation of the study is that the attrition rate was
relatively high. The most common reason for drop-
out was lack of time. The reported effect of the ster-
oid injections among drop-out participants was com-
parable to the compliant subjects (n = 12 vs. n = 16;
missing data, n = 6), indicating that the initial effect
of the study participation was not the main reason
for leaving the study.
Conclusions
In patients with SAPS and enlarged subacromial bursa,
10 weeks of unilateral exercise of the symptomatic
shoulder, given as an add-on to two sequential steroid
injections into the subacromial bursa, did not improve
the primary outcome of shoulder pain, compared to
exercise of the asymptomatic shoulder (control). Effects
on functional ability, clinical impingement signs, or
muscle strength when compared to exercise of the
uninvolved shoulder were also comparable between
groups. The results indicate a short-term benefit on
US-assessed impingement test immediately after the
exercise program; however, this effect was not main-
tained at the 26-week follow up.
Additional file
Additional file 1: The exercise intervention. The file describes the
exercise intervention in detail. (DOC 35 kb)
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